Rhythm Pharmaceuticals Cash from Financing (TTM) Insights

Rhythm Pharmaceuticals Inc (RYTM)

38.31 +0.16 (+0.42%) USD | NASDAQ | Apr 26, 16:00

38.31 0.00 (0.00%) After-Hours: 17:57

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	74.37M
September 30, 2023	89.31M
June 30, 2023	174.83M
March 31, 2023	213.30M
December 31, 2022	213.83M
September 30, 2022	196.56M
June 30, 2022	38.41M
March 31, 2022	1.295M
December 31, 2021	166.48M
September 30, 2021	166.80M
June 30, 2021	167.09M
March 31, 2021	166.89M
December 31, 2020	2.009M

Date	Value
September 30, 2020	163.55M
June 30, 2020	163.55M
March 31, 2020	163.86M
December 31, 2019	163.47M
September 30, 2019	1.664M
June 30, 2019	2.14M
March 31, 2019	165.00M
December 31, 2018	164.69M
September 30, 2018	290.19M
June 30, 2018	310.18M
March 31, 2018	146.82M
December 31, 2017	167.20M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

1.295M

Minimum

Mar 2022

213.83M

Maximum

Dec 2022

122.60M

Average

163.55M

Median

Sep 2020

Cash from Financing (TTM) Benchmarks